Track Cambridge Cognition Holdings Plc — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Cambridge Cognition Holdings Plc COG.L · Stock Open Cambridge Cognition Holdings Plc in new tab

28.00 GBX
EPS
-0.03
P/B
6.17
ROE
-62.08
Beta
0.81
Target Price
61.67 GBX
Loading chart...
Key Metrics
Earnings dateMay 5, 2027
EPS-0.03
Book Value0.05
Price to Book6.17
Debt/Equity10.91
% Insiders32.701%
Growth
Revenue Growth0.17%
Estimates
Forward P/E-10.84
Forward EPS-0.03
Target Mean Price61.67

DCF valuation

Model fair value for Cambridge Cognition Holdings Plc (COG.L)
Result
Sign in to run the valuation for COG.L.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
3 analysts · consensus Strong buy · mean target 61.67 GBX (low 56.00, high 72.00) · as of 13 Oct 2026
Low 56.00
Mean 61.67
High 72.00
Price 28.00
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Cambridge Cognition Holdings Plc Logo Cambridge Cognition Holdings Plc Analysis (COG.L)

United Kingdom Health Care Official Website Stock

Is Cambridge Cognition Holdings Plc a good investment? Cambridge Cognition Holdings Plc (COG.L) is currently trading at 28.00 GBX. Market analysts have a consensus price target of 61.67 GBX. This suggests a potential upside from current levels.

Earnings Schedule: Cambridge Cognition Holdings Plc is expected to release its next earnings report on May 5, 2027. The market consensus estimate for Forward EPS is -0.03.

Investor FAQ

Does Cambridge Cognition Holdings Plc pay a dividend?

No, it does not currently pay a dividend.

What asset class is Cambridge Cognition Holdings Plc?

Cambridge Cognition Holdings Plc is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be May 5, 2027. The company currently has a trailing EPS of -0.03.

Company Profile

Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers sensitive, precise and objective measures of cognitive function, correlated to neural networks; voice analysis, an automated speech recognition tool for monitoring neurological and psychiatric disorders; and high frequency testing that detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), a digital bespoke questionnaires that collects data within tight deadlines; and data quality management. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.

Exchange Ticker
LSE (United Kingdom) COG.L
FRA (Germany) 1M7.F
Trades
Dividend History paid per year (GBX)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
May 31, 2024 1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion